Skip to main content
World Journal of Gastroenterology logoLink to World Journal of Gastroenterology
. 2006 Nov 14;12(42):6893–6897. doi: 10.3748/wjg.v12.i42.6893

Identification of differentially expressed genes in mouse hepatocarcinoma ascites cell line with low potential of lymphogenous metastasis

Xiao-Nan Cui 1,2, Jian-Wu Tang 1,2, Li Hou 1,2, Bo Song 1,2, Li-Ying Ban 1,2
PMCID: PMC4087450  PMID: 17106944

Abstract

AIM: To identify genes differentially expressed in mouse hepatocarcinoma ascites cell line with low potential of lymphogenous metastasis.

METHODS: A subtracted cDNA library of mouse hepatocarcinoma cell line with low potential of lympho-genous metastasis Hca-P and its synogenetic cell line Hca-F with high metastatic potential was constructed by suppression subtracted hybridization (SSH) method. The screened clones of the subtracted library were sequenced and GenBank homology search was performed.

RESULTS: Fifteen differentially expressed cDNA fragments of Hca-P were obtained which revealed 8 known genes, 4 expressed sequence tags (ESTs) and 3 cDNAs showed no homology.

CONCLUSION: Tumor metastasis is an incident involving multiple genes. SSH is a useful technique to detect differentially expressed genes and an effective method to clone novel genes.

Keywords: Suppression subtracted hybridization, Liver neoplasm, Metastasis suppression genes

INTRODUCTION

Tumor metastasis is an incident involving multiple genes. However, the number of metastasis related genes available nowadays is very limited to elucidate the puzzling process of metastasis. Therefore, more attentions have been paid to screen candidate genes responsible for metastasis by high throughput technique. Hca-P and Hca-F are a pair of synogenetic mouse hepatocarcinoma ascites cell lines, possessing a specific potential of lymphogenous metastasis when inoculated subcutaneously into 615 mice, Hca-P showing a low metastatic potential (< 30%), while Hca-F showing a high potential (> 80%)[1]. In the current study, we employed suppressive subtracted hybridization (SSH) technique to identify differentially expressed genes specific for Hca-P in an effort to obtain candidate genes related to lymphogenous metastasis of hepatocarcinoma in mice.

MATERIALS AND METHODS

Hca-F and Hca-P have been established and maintained by our laboratory[1]; inbred 615-mice were provided by the experimental animal center of our university.

Determination of lymph node metastatic rates of Hca-P and Hca-F

Sixty inbred 615-mice were randomly divided into 2 groups. The Hca-P and Hca-F tumor cell lines were inoculated at 2 × 106 tumor cells of approximately 0.1 mL cell suspension into each mouse subcutaneously in each group. The mice were decapitated on the 28th day post-inoculation. The implanted tumor and the regional lymph nodes were removed and paraffin sections of tissues were HE stained and examined under microscope. The lymph node metastatic rates of Hca-F and Hca-P tumor cells were calculated.

Construction of a subtracted cDNA library by SSH

Preparation of total RNA and mRNA: Isolation of total RNA was performed by TRIZOLTM(GIBCOBRL) and that of mRNA was carried out according to the protocol of oligotex mRNA spin column purification kit (Qiagen). The quantity and integrity of mRNA were detected by ultraviolet spectrometer and by electrophoresis on a denaturing formaldehyde agarose stained by EB. mRNA of Hca-P served as tester and mRNA of Hca-F as driver. SSH was performed between tester and driver by a PCR selectTM cDNA subtraction kit and 50 × PCR enzyme kit (Clontech, Heidelberg, Germany) following the instructions of the manufacturer.

dscDNA synthesis and digestion with RsaI: Briefly, 2 μg aliquots of each of poly (A+) mRNA from the tester and the pooled driver were subjected to dscDNA synthesis. Thereafter, they were purified by passing through Chroma spin-400 columns (Clontech, USA). Each purified dscDNA was digested with RsaI.

ligation to adaptor 1 and 2R: The tester cDNAs were subdivided into 2 equal groups and then ligated to adaptor 1 and 2R in separate ligation reactions. Ligation efficiency analysis was performed by amplifying ligation products with G3PDH 3’ primer/PCR primer 1 and G3PDH 3’ primer/G3PDH 5’ primer, respectively, and their intensity was compared.

Subtractive hybridization: Subtractive hybridization was performed by annealing an excess of driver cDNAs with each sample of adaptor-ligated tester cDNAs. The cDNAs were heat-denatured and incubated at 68°C for 8 h. After the first hybridization, the 2 samples were mixed together and hybridized again with freshly heat-denatured driver cDNAs for 20 h at 68°C. Two rounds of hybridization would generate a normalized population of tester-specific cDNAs with different adaptors at each end. After filling in the ends, 2 rounds of PCR amplification were performed to enrich desired cDNAs containing both adaptors by exponential amplification of these products[2]. The optimized cycles for the first and second PCRs were 27 and 13 respectively to increase representation and reduce redundancy of subtracted cDNA libraries.

Analysis of subtractive efficiency: Secondary PCR products were used as templates for PCR amplification of human G3PDH for 18, 23, 28 and 33 cycles respectively to assure subtraction efficiency. PCR products were run on 1.8% agarose gel.

Ligation of the subtracted library into a TA vector

Products of the secondary PCR reactions were cloned into a pT Adv vector (Clontech) and the resultant ligation products were then transformed into DH5α E. coli competent cells. The bacteria were subsequently grown in 800 μL of liquid Luria-Bertani medium and allowed to incubate for 45 min at 37°C with shaking at 150 rpm. Thereafter, the cells were plated onto agar plates containing ampicillin (50 μg/mL), 5-bromo-4-chloro-3-indoly-b-D-galactoside (X-gal; 20 μg/cm2) and iso-ploprl-b-D-thiogalactoside (IPTG; 12.1 μg/cm2) and incubated overnight at 37°C. Individual recombinant white clones were picked and grown in single line pattern onto Luria-Bertani agar solid medium containing ampicillin and allowed to incubate at 37°C for 6-7 h before single clone was picked from single-line pattern agar medium and allowed to grow in Luria-Bertani liquid medium containing ampicillin overnight at 37°C with shaking at 150 r/min.

Identification of the subtracted clones

Plasmids of candidate positive clones from subtracted cDNA library were isolated and amplified by PCR with nested primer 1 and primer 2. Meanwhile the product of PCR was detected by agarose gel electrophoresis.

Sequencing and BLAST homology search

Randomly screened 14 positive clones from the subtracted cDNA library were sequenced by T7/SP6 chain termination reaction in TaKaRa (DaLian, China). Nucleic acid homology searches were subsequently performed at the National Center of Biotechnology Information (National Institutes of Health, Bethesda, Md., NCBI).

RESULTS

Determination of lymph node metastatic rates of Hca-P and Hca-F

Implanted tumors of both Hca-P tumor-bearing mice and Hca-F tumor-bearing mice were palpable on 7th day post-inoculation. On the 28th day post-inoculation, 10% Hca-P cells bearing mice developed metastatic regional lymph nodes (3/30), while 80% Hca-F cells bearing mice developed metastatic regional lymph nodes (24/30).

Total RNA and mRNA analysis

The RNA samples electrophoresed on 1% agarose/EB gel exhibited 2 typical bands, corresponding to ribosomal 28s and 18s RNA, respectively, with a ratio of intensities > 2:1 and 1.9, ideal A260/A28 ratios of both samples obtained, indicating high integrity and purification of the total RNA we obtained. mRNA samples appeared as a smear with weak ribosomal RNA band: a high-quality mRNA was purified.

RsaIdigestion

Both the digested cDNA and undigested cDNA usually presented as smears. However, their patterns were different. The digested cDNA fragments became shorter after RsaI digestion (Figure 1).

Figure 1.

Figure 1

The effect of RsaIdigestion. Lane 1, 3: cDNA of Hca-F and Hca-P cells; Lane 2, 4: cDNA of Hca-F and Hca-P cells after RsaIdigestion; M: DNA marker DL2000.

Ligation efficiency analysis

Intensity of the PCR product amplified using one gene-specific primer (G3PDH 3’ primer) and PCR primer 1 was 25% more than that of PCR product amplified using two gene-specific primers (G3PDH 3’ primer and 5’ primer). Ligation efficiency was > 25%, ensuring enough tester cDNA in the following hybridization (Figure 2).

Figure 2.

Figure 2

Ligation efficiency analysis. Lane 1: Tester-1 as template, G3PDH 3’Primer and PCR Primer1; Lane 2: Tester-1 as template, G3PDH 3‘Primer and G3PDH 5‘Primer; Lane 3: Tester-2R as template, G3PDH 3‘Primer and PCR Primer1; Lane 4: Tester-2R as template, G3PDH 3‘Primer and G3PDH 5‘Primer.

Construction of subtracted cDNA library by SSH

PCR products of the subtracted and unsubtracted usually looked like smears with or without discrete bands. However, the patterns between them were different

(Figure 3).

Figure 3.

Figure 3

The results of secondary PCR amplification. Lane 1-3: Product of primary PCR amplification, Lane 4: secondary PCR amplification product of unsubtracted cDNA, Lane 5: secondary PCR amplification product of subtracted cDNA, Lane 6: secondary PCR amplification product of PCR control cDNA, M: DNA Marker DL2000.

Analysis of subtractive efficiency

Subtraction efficiency analysis showed the effectively reduced amount of non-differentially expressed genes. In unsubtracted cDNA libraries, housekeeping gene G3PDH PCR products were visible after 23 cycles of amplification and became saturated after 23-28 cycles. However, subtracted libraries required 33 cycles for G3PDH to be detected (Figure 4).

Figure 4.

Figure 4

Analysis of subtraction effect. PCR was performed on subtracted (Lane 1-4) or unsubtracted (Lane 5-8) secondary PCR product with G3PDH 5’Primer and 3’primer. Lanes 1, 5: 20 cycles, Lanes 2, 6: 25 cycles, Lanes 3, 7: 30 cycles, Lanes 4, 8: 35 cycles. M: DNA marker DL2000.

Differential screening of subtracted cDNA libraries

The subtracted cDNA libraries were composed of 995 positive clones, of which 200 clones were randomly picked up and plasmids of the candidate positive clones were isolated and amplified by PCR with nested primer 1 and primer 2. As a result, 189 positive clones showed PCR products of a size of 300-1000 bp (Figure 5).

Figure 5.

Figure 5

The results of clone PCR amplification. There was an average insert size of 300-1000 bp. M: DNA marker DL2000.

Sequencing and homology search

Fifteen screened clones randomly selected were sequenced and homology search (http://www.ncbi.hlm.nih.gov/BLAST/) revealed 8 known genes and 4 expressed sequence tags (ESTs). Three cDNAs showed no ho-mology and presumably represented novel genes (Table 1).

Table 1.

Homologue searching of the sequenced cDNA fragments from SSH library

Clone seriel number Size (bp) Sequence identity
1-3 508 Mus musculus Telomere repeat binding factors TRF1
3-5 543 Mus musculus Telomere repeat binding factors TRF2,
9-6 489 Mus musculus maspin
15-4 335 Mouse chromosome 3 clone RP 6-126M1
1-7 386 Mouse 7 d embryo whole body cDNA RIKEN full-length enrich library, clone 2210102k3
16-3 503 Mouse 5 d liver cells cDNA RIKEN full-length library enriched library, clone E330462F4
10-1 549 Mouse chromosome 17 clone RP 26-122M3
13-7 502 Mouse chromosome 4 clone RP13-110N10
9-8 340 EST-mouse
6-6 411 EST-mouse
11-2 390 EST-mouse
20-9 399 EST-mouse
23-3 470 Unknown
17-6 486 Unknown
12-3 344 Unknown

DISCUSSION

Tumor metastasis, as the leading cause of tumor related death, is a process involving multiple genes and their products. Elucidation of the gene expression profiles specific for tumor cells with different potential of metastasis might help in the understanding of the molecular mechanisms of metastasis. As one of the high throughput screening techniques, SSH technique has two distinct advantages: (1) it boasts a high subtraction efficiency; (2) it harbors an equalized representation of differentially expressed sequences which can separate effectively both high and low copy expressed genes mainly because of normalization[2]. von Stein et al[3] found about 94% positive rate in their research. Thus they considered confirmation of differentially expressed genes by Northern blot analysis for each clone obtained was probably unnecessary.

For a long time, studies have focused on the angiogenesis of tumors, but the roles of lymphatic vessels in tumor growth and metastasis were neglected. However, it is well known that lymphatic metastasis is mainly responsible for the spread of epithelial malignant tumors, and is closely related to the prognosis of patients.

Hca-P and Hca-F are a pair of synogenetic mouse hepatocarcinoma ascites cell lines presenting a specific potential of lymphogenous metastasis with a significant difference in their potential of metastasis[1]. Candidate genes involved in lymphogenous metastasis are supposed to be among the differentially expressed genes.

Using Hca-P as a tester, Hca-F as a driver, and we employed SSH technique to identify differentially expressed genes specific for Hca-P(low metastatic potential) so as to obtain candidate suppressor genes of lymphogenous metastasis. Fifteen screened clones randomly selected were sequenced and homology search revealed 8 known genes as TRF1, TRF2(telomere repeat binding factor 1, 2) ; maspin; mouse 7 days embryo whole body cDNA, RIKEN full-length enriched library clone 2210102k3; mouse 5 days liver cells cDNA, RIKEN full-length enriched library, clone E330462F4; mouse chromosome 3 clone RP 6-126M1;mouse chromosome 17 clone RP 26-122M3 and mouse chromosome 4 clone RP13-110N10. Studies showed TRF1, and TRF2 play important roles in genome stabilization [4-11] and are down-regulated in some malignant cell lines and tumor tissues[12-18]. In hematopoietic carcinogenesis, gene expression of telomerase suppressors such as TRF and TIN2, is decreased. mRNA encoding TRF1 and TRF2 when gastric cancer becomes more deeply invaded, is significantly decreased, indicating a negative association with tumor progression. Of the 8 known fragments, one showed high homology to mouse Maspin gene. Serving as one of the few p53-targeted genes involved in tumor invasion and metastasis, Maspin, a member of the serpin family, has been reported to suppress metastasis and angiogenesis in breast and prostate cancers, and is closely correlated with their clinical manifestations[19-31]. It indicates that SSH in our study is capable of enriching metastasis related genes.

Another 5 known fragments were attributed to embryo genes. Embryo genes AFP and CEA are overexpressed in hepatocarcinoma and other malignant tumors, indicating a possible association between embryo development and tumor. Embryo genes were also found in our previously established SSH library which contains candidate tumor metastasis genes[32]. These data showed that up-regulated expression of embryo genes during metastasis is not a casual event. Their roles in tumor metastasis need to be clarified. Moreover, 4 cDNA fragments demonstrated homology with 4 ESTs-mouse and 3 cDNA fragments showed no homology and presumably represented novel genes[33].

In summary, the findings of our study suggest that the lymphatic invasiveness of tumor cells is determined by multiple genes and co-factors with complex cellular signal pathways. Further functional study of the candidate novel genes might provide clues to molecular mechanism of tumor metastasis.

Footnotes

Supported by National Natural Science Foundation of China, No. 30500586

S- Editor Liu Y L- Editor Zhu LH E- Editor Ma WH

References

  • 1.Ji Y, Ling MY, Li Y, Xie H. Effect of cell fusion on metastatic ability of mouse hepatocarcinoma cell lines. World J Gastroenterol. 1999;5:22–24. doi: 10.3748/wjg.v5.i1.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Diatchenko L, Lukyanov S, Lau YF, Siebert PD. Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes. Methods Enzymol. 1999;303:349–380. doi: 10.1016/s0076-6879(99)03022-0. [DOI] [PubMed] [Google Scholar]
  • 3.von Stein OD, Thies WG, Hofmann M. A high throughput screening for rarely transcribed differentially expressed genes. Nucleic Acids Res. 1997;25:2598–2602. doi: 10.1093/nar/25.13.2598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Karlseder J. Telomere repeat binding factors: keeping the ends in check. Cancer Lett. 2003;194:189–197. doi: 10.1016/s0304-3835(02)00706-1. [DOI] [PubMed] [Google Scholar]
  • 5.Deng Z, Atanasiu C, Burg JS, Broccoli D, Lieberman PM. Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. J Virol. 2003;77:11992–12001. doi: 10.1128/JVI.77.22.11992-12001.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wu G, Jiang X, Lee WH, Chen PL. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1. Cancer Res. 2003;63:2589–2595. [PubMed] [Google Scholar]
  • 7.Iwano T, Tachibana M, Reth M, Shinkai Y. Importance of TRF1 for functional telomere structure. J Biol Chem. 2004;279:1442–1448. doi: 10.1074/jbc.M309138200. [DOI] [PubMed] [Google Scholar]
  • 8.Kishi S, Lu KP. A critical role for Pin2/TRF1 in ATM-dependent regulation. Inhibition of Pin2/TRF1 function complements telomere shortening, radiosensitivity, and the G(2)/M checkpoint defect of ataxia-telangiectasia cells. J Biol Chem. 2002;277:7420–7429. doi: 10.1074/jbc.M111365200. [DOI] [PubMed] [Google Scholar]
  • 9.Iizuka N, Mori N, Tamesa T, Tangoku A, Oka M. Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma. Anticancer Res. 2003;23:43–47. [PubMed] [Google Scholar]
  • 10.Nosaka K, Kawahara M, Masuda M, Satomi Y, Nishino H. Association of nucleoside diphosphate kinase nm23-H2 with human telomeres. Biochem Biophys Res Commun. 1998;243:342–348. doi: 10.1006/bbrc.1997.8097. [DOI] [PubMed] [Google Scholar]
  • 11.Li B, de Lange T. Rap1 affects the length and heterogeneity of human telomeres. Mol Biol Cell. 2003;14:5060–5068. doi: 10.1091/mbc.E03-06-0403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Yang SW, Kim DH, Lee JJ, Chun YJ, Lee JH, Kim YJ, Chung IK, Kim WT. Expression of the telomeric repeat binding factor gene NgTRF1 is closely coordinated with the cell division program in tobacco BY-2 suspension culture cells. J Biol Chem. 2003;278:21395–21407. doi: 10.1074/jbc.M209973200. [DOI] [PubMed] [Google Scholar]
  • 13.Yamada K, Yagihashi A, Yamada M, Asanuma K, Moriai R, Kobayashi D, Tsuji N, Watanabe N. Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells. Anticancer Res. 2002;22:1315–1320. [PubMed] [Google Scholar]
  • 14.Otsuka T, Uchida N, Arima F, Shigematsu H, Fukuyama T, Maeda M, Sugio Y, Itoh Y, Niho Y. Down-regulation of human telomeric protein TRF1 gene expression during myeloid differentiation in human hematopoietic cells. Int J Hematol. 2000;71:334–339. [PubMed] [Google Scholar]
  • 15.Fujimoto R, Kamata N, Taki M, Yokoyama K, Tomonari M, Nagayama M, Yasumoto S. Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells. Oral Oncol. 2003;39:445–452. doi: 10.1016/s1368-8375(03)00003-4. [DOI] [PubMed] [Google Scholar]
  • 16.Saito K, Yagihashi A, Nasu S, Izawa Y, Nakamura M, Kobayashi D, Tsuji N, Watanabe N. Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer. Jpn J Cancer Res. 2002;93:253–258. doi: 10.1111/j.1349-7006.2002.tb02166.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yamada M, Tsuji N, Nakamura M, Moriai R, Kobayashi D, Yagihashi A, Watanabe N. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers. Anticancer Res. 2002;22:3303–3307. [PubMed] [Google Scholar]
  • 18.Miyachi K, Fujita M, Tanaka N, Sasaki K, Sunagawa M. Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer. J Exp Clin Cancer Res. 2002;21:269–275. [PubMed] [Google Scholar]
  • 19.Dokras A, Gardner LM, Kirschmann DA, Seftor EA, Hendrix MJ. The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development. Placenta. 2002;23:274–280. doi: 10.1053/plac.2001.0784. [DOI] [PubMed] [Google Scholar]
  • 20.Ngamkitidechakul C, Warejcka DJ, Burke JM, O'Brien WJ, Twining SS. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J Biol Chem. 2003;278:31796–31806. doi: 10.1074/jbc.M302408200. [DOI] [PubMed] [Google Scholar]
  • 21.Zhang M, Volpert O, Shi YH, Bouck N. Maspin is an angiogenesis inhibitor. Nat Med. 2000;6:196–199. doi: 10.1038/72303. [DOI] [PubMed] [Google Scholar]
  • 22.Biliran H Jr, Sheng S. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res. 2001;61:8676–8682. [PubMed] [Google Scholar]
  • 23.Zhang W, Zhang M. Tissue microarray analysis of maspin expression and its reverse correlation with mutant p53 in various tumors. Int J Oncol. 2002;20:1145–1150. [PubMed] [Google Scholar]
  • 24.Khalkhali-Ellis Z, Hendrix MJ. Nitric oxide regulation of maspin expression in normal mammary epithelial and breast cancer cells. Am J Pathol. 2003;162:1411–1417. doi: 10.1016/S0002-9440(10)64274-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Maass N, Teffner M, Rösel F, Pawaresch R, Jonat W, Nagasaki K, Rudolph P. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol. 2001;195:321–326. doi: 10.1002/path.948. [DOI] [PubMed] [Google Scholar]
  • 26.Chen Z, Fan Z, McNeal JE, Nolley R, Caldwell MC, Mahadevappa M, Zhang Z, Warrington JA, Stamey TA. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. J Urol. 2003;169:1316–1319. doi: 10.1097/01.ju.0000050648.40164.0d. [DOI] [PubMed] [Google Scholar]
  • 27.Manzotti M, Dell'Orto P, Maisonneuve P, Zurrida S, Mazzarol G, Viale G. Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer. 2001;95:307–312. doi: 10.1002/1097-0215(20010920)95:5<307::aid-ijc0153>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  • 28.Maass N, Hojo T, Rösel F, Ikeda T, Jonat W, Nagasaki K. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem. 2001;34:303–307. doi: 10.1016/s0009-9120(01)00220-x. [DOI] [PubMed] [Google Scholar]
  • 29.Sabbatini R, Federico M, Morselli M, Depenni R, Cagossi K, Luppi M, Torelli G, Silingardi V. Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy. J Clin Oncol. 2000;18:1914–1920. doi: 10.1200/JCO.2000.18.9.1914. [DOI] [PubMed] [Google Scholar]
  • 30.Machtens S, Serth J, Bokemeyer C, Bathke W, Minssen A, Kollmannsberger C, Hartmann J, Knüchel R, Kondo M, Jonas U, et al. Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer. 2001;95:337–342. doi: 10.1002/1097-0215(20010920)95:5<337::aid-ijc1059>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  • 31.Yasumatsu R, Nakashima T, Hirakawa N, Kumamoto Y, Kuratomi Y, Tomita K, Komiyama S. Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck. 2001;23:962–966. doi: 10.1002/hed.1139. [DOI] [PubMed] [Google Scholar]
  • 32.Cui XN, Tang JW, Hou L, Song B, Li L, Liu JW. Screening differentially expressed genes in mouse hepatocarcinoma ascites cell line with high potential of lymphatic metastasis. World J Gastroenterol. 2005;11:1837–1842. doi: 10.3748/wjg.v11.i12.1837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, Merril CR, Wu A, Olde B, Moreno RF. Complementary DNA sequencing: expressed sequence tags and human genome project. Science. 1991;252:1651–1656. doi: 10.1126/science.2047873. [DOI] [PubMed] [Google Scholar]

Articles from World Journal of Gastroenterology : WJG are provided here courtesy of Baishideng Publishing Group Inc

RESOURCES